In Victory For Teva, Federal Circuit Sends Accupril Patent Suit Back To New Jersey
The U.S. Court of Appeals for the Federal Circuit has ruled in favor of Israeli generics maker Teva Pharmaceuticals in a lawsuit brought by Pfizer Inc., asking a New Jersey federal...To view the full article, register now.
Already a subscriber? Click here to view full article